HIV/AIDS surveillance in Europe 2017 - 2016 data

Surveillance report
Publication series: HIV/AIDS Surveillance in Europe
Time period covered: 1 January - 31 December 2016
Citation Link

European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2017 – 2016 data. Stockholm: ECDC; 2017.

Copy citation to clipboard

Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2016, 29 444 people were diagnosed with HIV in the 31 countries of the EU/EEA, with a rate of 5.9 per 100 000. The rate was higher among men than women (8.9 versus 2.6 cases per 100 000 population).

Executive summary

Similar to recent years, the highest proportion of HIV diagnoses (40%) was reported to be in men who have sex with men (MSM). However, for the first time in a number of years, several countries reported a decline in new HIV diagnoses, even after adjusting for reporting delay.

While the data in this year’s report indicate alarming rates and increases in new diagnoses in some parts of eastern and central Europe over the last decade, at the same time there has been a tendency towards stabilising or even decreasing rates in some EU/EEA countries.

Trends by transmission mode, for example, show that the number of HIV diagnoses among MSM in the EU/EEA decreased slightly in 2016 and the number of heterosexually acquired cases has decreased steadily over the last decade.

Moreover, in the EU/EEA, the number of AIDS cases, and the number of AIDS-related deaths, has consistently declined since the mid-1990s.

Publication data


Presentation: HIV/AIDS Surveillance in Europe 2017 (2016 data)

Presentation -
Period: 01 Jan 2016 - 31 Dec 2016

ECDC - WHO/Europe presentation of HIV/AIDS Surveillance in Europe 2017 (2016 data)

Related updates on HIV/AIDS


HIV Combination prevention: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)

Technical report -


Spring European Testing Week 2020

15 May 2020 - 22 May 2020


Evidence of the immunogenicity of the HPV vaccine in HIV-infected men and women

Table -


Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction

Technical guidance -


Evidence of the safety of the HPV vaccine in HIV-infected men and women

Table -